Patent directory · USPTO A61K / A61P
Patents matching “inhibitors”
2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11179394
Method for treating cancer using a combination of Chk1 and ATR inhibitors
granted -
US 11179400
Heterocyclic compounds as RSV inhibitors
granted -
US 11180466
2-benzoylaminobenzamide derivatives as Bcl-3 inhibitors
granted -
US 11174219
Neprilysin inhibitors
granted -
US 11173145
Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
granted -
US 11174232
Substituted heterocyclyl derivatives as CDK inhibitors
granted -
US 11168083
Inhibitors of Plasma Kallikrein and uses thereof
granted -
US 11168082
Pyrrolo[2,3-C]pyridines and related analogs as LSD-1 inhibitors
granted -
US 11168071
Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use
granted -
US 11166942
Inhibitors of integrated stress response pathway
granted -
US 2021338651
METHODS FOR THE ADMINISTRATION OF COMT INHIBITORS
granted -
US 11154519
Inhibitors and their uses
granted -
US 11155549
Ester and carbonate pyrimidine compounds as JAK kinase inhibitors
granted -
US 11155559
Sulfonyl-substituted isoquinolines as inhibitors of RHO kinase and hERG potassium channel activity
granted -
US 11147885
ASH1L inhibitors and methods of treatment therewith
granted -
US 11147801
Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors
granted -
US 11141418
Methods and compositions for KRAS inhibitors
granted -
US 11135225
Cancer treatments using combinations of CDK and ERK inhibitors
granted -
US 11135222
Aurora kinase inhibitors
granted -
US 11135204
Anhydrous compositions of mTOR inhibitors and methods of use
granted -
US 11129841
CD73 inhibitors
granted -
US 11130759
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors
granted -
US 11129856
Methods of treating chronic wounds with amniotic fluid having elevated levels of tissue inhibitors of matrix metalloproteinases
granted -
US 11129828
Pyridazinone compounds and their use as DAAO inhibitors
granted